Related references
Note: Only part of the references are listed.Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
Antonia K. Roseweir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
Antonia K. Roseweir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-kappa B Inducing Kinase
Nicole Blaquiere et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Role of the NFκB-signaling pathway in cancer
Longzheng Xia et al.
ONCOTARGETS AND THERAPY (2018)
The Prognostic Role of the Non-Canonical Nuclear Factor-Kappa B Pathway in Renal Cell Carcinoma Patients
Joanne Lua et al.
UROLOGIA INTERNATIONALIS (2018)
High IKK expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer
Lindsay Bennett et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers
Nahoum G. Anthony et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)
Georgette M. Castanedo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway
Lin Jin et al.
CANCER RESEARCH (2017)
The non-canonical NF-κB pathway in immunity and inflammation
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2017)
IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line
Martina Leopizzi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis
Yvette J. Merga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells
Zhen Yang et al.
BRITISH JOURNAL OF CANCER (2016)
Chronic lymphocytic leukaemia
Lydia Scarfo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
NF-κB deregulation in splenic marginal zone lymphoma
Valeria Spina et al.
SEMINARS IN CANCER BIOLOGY (2016)
Noncanonical NF-κB Signaling in Health and Disease
Goekhan Cildir et al.
TRENDS IN MOLECULAR MEDICINE (2016)
PI3K/Akt promotes feedforward mTORC2 activation through IKKα
Han C. Dan et al.
ONCOTARGET (2016)
LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway
Jiantao Jia et al.
ONCOTARGET (2016)
Prognostic significance of RelB overexpression in non-small cell lung cancer patients
Hualong Qin et al.
THORACIC CANCER (2016)
Structural Basis for the Activation of IKK1/α
Smarajit Polley et al.
CELL REPORTS (2016)
NIK regulates MT1-MMP activity and promotes glioma cell invasion independently of the canonical NF-κB pathway
C. L. Duran et al.
ONCOGENESIS (2016)
Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer
L. L. Qu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Larry Mansouri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
Sinyi Kong et al.
JOURNAL OF IMMUNOLOGY (2015)
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Yinghui Li et al.
NATURE CELL BIOLOGY (2015)
BRAF-induced tumorigenesis is IKKα-dependent but NF-κB-independent
Pol Margalef et al.
Science Signaling (2015)
Apigenin blocks IKKa activation and suppresses prostate cancer progression
Sanjeev Shukla et al.
ONCOTARGET (2015)
An Oncogenic Role for Alternative NF-κB Signaling in DLBCL Revealed upon Deregulated BCL6 Expression
Baochun Zhang et al.
CELL REPORTS (2015)
BRAF-induced tumorigenesis is IKKα-dependent but NF-κB-independent
Pol Margalef et al.
Science Signaling (2015)
Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner
Mo Shen et al.
MOLECULAR MEDICINE REPORTS (2015)
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
P. Baliakas et al.
LEUKEMIA (2015)
Non-conventional functions for NF-κB members: the dark side of NF-κB
L. Espinosa et al.
ONCOGENE (2015)
Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice
Sanjeev Shukla et al.
PLOS ONE (2015)
NF-κB-Mediated Regulation of Osteoclastogenesis
Brendan F. Boyce et al.
ENDOCRINOLOGY AND METABOLISM (2015)
Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib
Dominik Wodarz et al.
BLOOD (2014)
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment
Sabina Chiaretti et al.
LEUKEMIA & LYMPHOMA (2014)
NON-CANONICAL NF-κB SIGNALING DRIVES THE AGGRESSIVE INVASIVENESS OF GLIOBLASTOMA
Evan Cherry et al.
NEURO-ONCOLOGY (2014)
Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
Massimo Ammirante et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence
Alessio Iannetti et al.
PLOS GENETICS (2014)
NFκB regulates expression of Polo-like kinase 4
Adeline C. Ledoux et al.
CELL CYCLE (2013)
An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence
Massimo Ammirante et al.
GENES & DEVELOPMENT (2013)
Crystal Structure of a Human IκB Kinase β Asymmetric Dimer
Shenping Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Proteasome Inhibition by Bortezomib Increases IL-8 Expression in Androgen-Independent Prostate Cancer Cells: The Role of IKKα
Subrata Manna et al.
JOURNAL OF IMMUNOLOGY (2013)
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities
Douglas W. McMillin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Deficiency of Innate and Acquired Immunity Caused by an IKBKB Mutation
Ulrich Pannicke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity
Heike Doeppler et al.
PLOS ONE (2013)
A Structural Basis for IκB Kinase 2 Activation Via Oligomerization-Dependent Trans Auto-Phosphorylation
Smarajit Polley et al.
PLOS BIOLOGY (2013)
Characterization of the Inhibitor of KappaB Kinase (IKK) Complex in Granulosa Cell Tumors of the Ovary and Granulosa Cell Tumor-Derived Cell Lines
Stacey Jamieson et al.
HORMONES & CANCER (2013)
Small-molecule inhibitors of I.B kinase (IKK) and IKK-related kinases
Sabin Llona-Minguez et al.
PHARMACEUTICAL PATENT ANALYST (2013)
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
Inhibitory kappa B kinases as targets for pharmacological regulation
Carly Gamble et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Understanding NIK Regulation from Its Structure
Zhihua Tao et al.
STRUCTURE (2012)
The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site
Gladys de Leon-Boenig et al.
STRUCTURE (2012)
A Truncated Form of IKKα Is Responsible for Specific Nuclear IKK Activity in Colorectal Cancer
Pol Margalef et al.
CELL REPORTS (2012)
IκB Kinases Modulate the Activity of the Androgen Receptor in Prostate Carcinoma Cell Lines
Garima Jain et al.
NEOPLASIA (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response
Sandra Gardam et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
NF-kappa B in the regulation of epithelial homeostasis and inflammation
Andy Wullaert et al.
CELL RESEARCH (2011)
Non-canonical NF-κB signaling activation and regulation: principles and perspectives
Bahram Razani et al.
IMMUNOLOGICAL REVIEWS (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Crystal structure of inhibitor of κB kinase β
Guozhou Xu et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB Activation
Shaun Rosebeck et al.
SCIENCE (2011)
BAG3 is required for IKKα nuclear translocation and emergence of castration resistant prostate cancer
M. Ammirante et al.
CELL DEATH & DISEASE (2011)
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Yulia N. Demchenko et al.
BLOOD (2010)
NF-κB inducing kinase: A key regulator in the immune system and in cancer
Yee Mon Thu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
Hsiangling Teo et al.
NATURE CELL BIOLOGY (2010)
Notch-1 activates estrogen receptor-α-dependent transcription via IKKα in breast cancer cells
L. Hao et al.
ONCOGENE (2010)
IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical Pathway
Mazhar Adli et al.
PLOS ONE (2010)
Antigens in chronic lymphocytic leukemia-Implications for cell origin and leukemogenesis
Anders Rosen et al.
SEMINARS IN CANCER BIOLOGY (2010)
NIK is involved in constitutive activation of the alternative NF-κB pathway and proliferation of pancreatic cancer cells
Takashi Nishina et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Structural insights into IKKβ inhibition by natural products staurosporine and quercetin
Carolina M. Avila et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors
John Liddle et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Emanuela Rosati et al.
BLOOD (2009)
Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications
Teru Hideshima et al.
BLOOD (2009)
Constitutive non-canonical NFκB signaling in pancreatic cancer cells
Catherine E. Wharry et al.
CANCER BIOLOGY & THERAPY (2009)
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease
Martin Perez-Andres et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models
Gabriel Mbalaviele et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Geldanamycin inhibits tyrosine phosphorylation-dependent NF-κB activation
Julie Crevecoeur et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Marine natural products as targeted modulators of the transcription factor NF-κB
Florence Folmer et al.
BIOCHEMICAL PHARMACOLOGY (2008)
High-affinity interaction between IKKβ and NEMO
Yu-Chih Lo et al.
BIOCHEMISTRY (2008)
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana et al.
BLOOD (2008)
Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches
Paola Rizzo et al.
CANCER RESEARCH (2008)
Inhibition of Human Immunodeficiency Virus Type 1 Replication by Blocking IκB Kinase with Noraristeromycin
Kaori Asamitsu et al.
JOURNAL OF BIOCHEMISTRY (2008)
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery
Arup K. Ghose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Differential regulation of IKKα-mediated activation of IRF3/7 by NIK
Rui-Peng Wang et al.
MOLECULAR IMMUNOLOGY (2008)
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
Sivakumar Vallabhapurapu et al.
NATURE IMMUNOLOGY (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
IAP antagonists target cIAP1 to induce TNFα- dependent apoptosis
James E. Vince et al.
CELL (2007)
A role for IκB kinase 2 in bipolar spindle assembly
Jeffrey T. Irelan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Artemisolide is a typical inhibitor of IκB kinase β targeting cysteine-179 residue and down-regulates NF-κB-dependent TNF-α expression in LPS-activated macrophages
Byung Hak Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors
Makonen Belema et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation:: heterotypic oligomerization and TRAF2 recruitment
P. C. Lucas et al.
ONCOGENE (2007)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-α and IKK-β kinases
John A. Christopher et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Proinflammatory stimuli induce IKKα-mediated phosphorylation of PIAS1 to restrict inflammation and immunity
Bin Liu et al.
CELL (2007)
NF-κB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells
Laurent Lessard et al.
CELLULAR SIGNALLING (2007)
Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB
Wei-Chien Huang et al.
MOLECULAR CELL (2007)
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo et al.
NATURE (2007)
A transgenic model reveals important roles for the NF-κB alternative pathway (p100/p52) in mammary development and links to tumorigenesis
Linda Connelly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth
Rentian Feng et al.
BLOOD (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The alternative NF-κB pathway from biochemistry to biology:: Pitfalls and promises for future drug development
Emmanuel Dejardin
BIOCHEMICAL PHARMACOLOGY (2006)
Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit
Katie Schumm et al.
EMBO JOURNAL (2006)
IKKα regulates the mitotic phase of the cell cycle by modulating Aurora A phosphorylation
Shashi Prajapati et al.
CELL CYCLE (2006)
β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870
Chunyang Liang et al.
CELLULAR SIGNALLING (2006)
Signalling and survival pathways in multiple myeloma
Kurt Bommert et al.
EUROPEAN JOURNAL OF CANCER (2006)
Rational design of inhibitors that bind to inactive kinase conformations
Y Liu et al.
NATURE CHEMICAL BIOLOGY (2006)
IKKα regulates estrogen-induced cell cycle progression by modulating E2F1 expression
Z Tu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
I kappa B kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300
JE Hoberg et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK
R Waelchli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation
AKW Tse et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer:: an immunohistochemical study
L Lessard et al.
BRITISH JOURNAL OF CANCER (2005)
IκB kinase α regulates subcellular distribution and turnover of cyclin D1 by phosphorylation
YT Kwak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
J Moreaux et al.
BLOOD (2005)
Structural bioinformatics-based design of selective, irreversible kinase inhibitors
MS Cohen et al.
SCIENCE (2005)
Gene expression profiling in conjunction with physiological rescues of IKKα-null cells with wild type or mutant IKKα reveals distinct classes of IKKα/NF-κB-dependent genes
PE Massa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation
KJ Park et al.
MOLECULAR CELL (2005)
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs
J Hauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting NF-κB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells
C Frelin et al.
BLOOD (2005)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Increased expression of NF-κB subunits in human pancreatic cancer cells
NM Chandler et al.
JOURNAL OF SURGICAL RESEARCH (2004)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways
RC Wu et al.
MOLECULAR CELL (2004)
A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells
S Cuní et al.
LEUKEMIA (2004)
Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation
GT Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
JF Ohren et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: Results of an open-label Multicenter phase 2 study of efficacy, toxicity, and biological activity
P Richardson et al.
MAYO CLINIC PROCEEDINGS (2004)
Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation
GX Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK Complex
M Kobori et al.
CELL DEATH AND DIFFERENTIATION (2004)
The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis
DV Novack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice
JR Burke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
M Bentires-Alj et al.
ONCOGENE (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program
X Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD40 regulates the processing of NF-κB2 p100 to p52
HJ Coope et al.
EMBO JOURNAL (2002)
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2
N Kayagaki et al.
IMMUNITY (2002)
The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways
E Dejardin et al.
IMMUNITY (2002)
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
E Claudio et al.
NATURE IMMUNOLOGY (2002)
Immunocytochemistry reveals RANKL expression of myeloma cells
O Sezer et al.
BLOOD (2002)
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAG-3/TRAM-1) coactivator activity by IκB kinase
RC Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
YX Cao et al.
CELL (2001)
Regulation of β-catenin function by the IκB kinases
C Lamberti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
SD Catz et al.
ONCOGENE (2001)
Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway
U Senftleben et al.
SCIENCE (2001)
NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
S Kreuz et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Transcriptional regulation of the BCL-X gene by NF-κB is an element of hypoxic responses in the rat brain
JN Glasgow et al.
NEUROCHEMICAL RESEARCH (2001)
Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice
L Yin et al.
SCIENCE (2001)
NF-κB-inducing kinase regulates the processing of NF-κB2 p100
GT Xiao et al.
MOLECULAR CELL (2001)
Characterization of the recombinant IKK1/IKK2 heterodimer - Mechanisms regulating kinase activity
QK Huynh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Analysis of domains in the IKKα and IKKβ proteins that regulate their kinase activity
YT Kwak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes
S Mustapha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Share Paper
